Another profitable day for DailyStockPlays.com members
Stocks Gapping Up 2017-07-20
ANF Abercrombie & Fitch Company (ANF) said it will launch on July 26 Abercrombie & Fitch and abercrombie kids on Alibaba's (BABA) Tmall.
ALIM Alimera Sciences, Inc. (ALIM) announced that the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has given final approval to reduce the size of its ILUVIEN Registry Safety Study (IRISS).
NASDAQ:AMBC Ambac (NASDAQ:AMBC) The Office of the Commissioner of Insurance for the State of Wisconsin has reviewed the agreement between Ambac (NASDAQ:AMBC) and stakeholders of the segregated account and given it a thumbs up. The deal, says Ambac, will add about $461.4M, or $9.83 per share to adjusted book value. BTIG bull Mark Palmer calls the agreement one of two major catalysts he's looking for, and it should grease the way for catalyst number two - a settlement of rep and warranty litigation with Bank of America. His $26 price target is 45% above last night's close.
AVA Avista Corporation (AVA) Hydro One Limited (TSX: H) and Avista Corporation (AVA) today jointly announced a definitive merger agreement under which Hydro One will acquire Avista for C$67 (US$53) per share in a C$6.7 billion (US$5.3 billion) all-cash transaction. Together, Hydro One and Avista will create a North American leader in regulated electricity and natural gas business with over C$32.2 billion (US$25.4 billion) in combined assets. The transaction brings together two industry-leading regulated utilities with over 230 years of collective operational experience as well as shared corporate cultures and values. The combined entity will safely and reliably serve more than two million retail and industrial customers and hold assets throughout North America including Ontario, Washington, Oregon, Idaho, Montana and Alaska.
BVXV BiondVax Pharmaceuticals (BVXV) and the UNISEC consortium today reported statistically significant positive results from the Phase 2b clinical trial of M-001, BiondVax's universal flu vaccine candidate. The study had two primary endpoints: Safety and influenza-specific cellular immune responses. Both endpoints were achieved.
BBRY BlackBerry (BBRY) said Thursday that it has expanded its cybersecurity offerings for the public sector to now include SecuSUITE for Government. The new suite is a multi-platform solution for end-to-end encryption of voice calls and text messages.
HAWK Blackhawk Network (HAWK) reported Q2 EPS of $0.12, $0.07 better than the analyst estimate of $0.05. Revenue for the quarter came in at $463.1 million, may not compare, versus the consensus estimate of $215.39 million.
BX Blackstone Group L.P (BX) is looking to raise as much as $3 billion via its first Pan-Asia buyout fund that's focused on sectors such as high-end manufacturing and healthcare, according to a report from Reuters that cited people familiar with the plan. The company informed its limited partners about the plan and aims to lock in the first tranche of investment by the end of 2017, the people were cited as saying.
CAMT Camtek (CAMT) shares were higher 8% in recent pre-market trade after the automated technology provider said it has agreed to sell its PCB business to an affiliate of Principle Capital for $35 million. A total of $32 million will be paid in cash upon closing and an additional $3 million will be conditioned upon financial performance in 2018. The deal is expected to close in Q3.
DWCH Datawatch (DWCH) reported Q3 EPS of ($0.04), $0.02 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $9.07 million versus the consensus estimate of $8.83 million.
DFFN Diffusion Pharmaceuticals Inc. (DFFN) today reported the completion of a major production run of its lead drug candidate trans sodium crocetinate (TSC). This drug supply will be used in its planned Phase 3 trial which will test TSC in the treatment of newly diagnosed inoperable glioblastoma (GBM) brain cancer patients and is of sufficient quantity to support the entire trial. Diffusion plans to initiate this clinical trial by the end of 2017. “Diffusion has reached an important milestone for initiating the Phase 3 trial with this successful manufacture of Phase 3-ready TSC,” said David Kalergis, Diffusion’s Chairman and CEO. “In its End-of-Phase-2-Meeting response, the FDA required that any TSC used in upcoming Phase 3 studies must be made using commercially-ready processes, both for the active pharmaceutical ingredient (API) and formulated drug product. The necessary advanced production and formulation processes were implemented over the last eighteen months and were cleared with the FDA in June, immediately prior to the successful clinical trial supply production run earlier this month.”
HPJ Highpower International, Inc. (HPJ) announced preliminary second quarter 2017 results. Net sales is estimated to be in the range of $50.0 to $52.0 million, a 36% to 42% increase from $36.7 million in the same quarter of 2016. First half 2017 net sales are estimated to be in the range of $92.0 to $94.0 million, a 39% to 43% increase from $65.8 million in the same time period last year. Second quarter 2017 gross profit is estimated to be in the range of $11.0 to $12.0 million, a 44% to 58% increase from $7.6 million in the second quarter of 2016. Total first half 2017 gross profit is estimated to be in the $21to $22 million range, compared to $13.5 million in the first half of 2016, a 55% to 63% increase. Net income is estimated to be in the $3.5 to $4.1 million range, a 66% to 95% increase from $2.1 million in the same quarter of 2016. First half 2017 net income is estimated to be in the $6.0 to $6.6million range, a 250% to 288% increase from $1.7 million in the same period of 2016.
NKE Nike (NKE) Morgan Stanley upgraded from Equalweight to Overweight with a price target of $68.00 (from $56.00).
TEUM Pareteum (TEUM) awarded two new cloud services contracts from UK-based communications service providers for its on-demand hosted Home Location Register (HLR) services. These new three-year contracts represent more than 50,000 new subscriber equivalents and an additional $1 million to Pareteum's current revenue backlog, the company said.
PLXS Plexus Corp (PLXS) reported Q3 EPS of $0.74, $0.02 better than the analyst estimate of $0.72. Revenue for the quarter came in at $619 million versus the consensus estimate of $608.79 million. Plexus Corp sees Q4 2017 EPS of $0.77-$0.87, versus the consensus of $0.84. Plexus Corp sees Q4 2017 revenue of $660-770 million, versus the consensus of $674.8 million.
PII Polaris Industries (PII) on Thursday posted second quarter adjusted earnings of $1.16 per share, up from $1.09 a year ago, and ahead of analysts' expectations of $1.09 in a Capital IQ poll. Sales increased to $1.36 billion from $1.13 billion, also beating the $1.26 billion estimate. Polaris said it is raising full year sales guidance and narrowing its earnings per share outlook. Now it expects adjusted EPS to be in the range of $4.35 to $4.50 per share compared to the prior range between $4.25 to $4.50. Analysts have been expecting FY EPS of $4.42. Adjusted FY sales are now expected to be up 12% to 14% from previously up 10% to 13%.
SNY Sanofi (SNY) Belgium-based Ablynx said Thursday that it has entered into a research collaboration and global exclusive licensing agreement with Sanofi (SNY). Under the deal, Sanofi gains access to certain Nanobodies in Ablynx's portfolio as well as to Ablynx's scientists and nanobody platform in exchange for an upfront payment of EUR23 million ($26.5 million) comprised of license and option fees. Ablynx will also receive research funding of EUR8 million for the initially selected targets.
SRPT Sarepta Therapeutics (SRPT) reported Q2 EPS of ($0.46), $0.45 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $35 million versus the consensus estimate of $22.38 million. Guidance: Raises FY2017 guidance to $125-130 million.
SHLD Sears Holdings (SHLD) said it is launching Kenmore products on Amazon.com (AMZN) and is integrating the full line of Kenmore Smart appliances with Amazon Alexa. Kenmore Smart connected room air conditioners integrated with Alexa are now available on Amazon.com, it said.
TMUS T-Mobile (TMUS) reported Q2 EPS of $0.67, $0.29 better than the analyst estimate of $0.38. Revenue for the quarter came in at $10.2 billion versus the consensus estimate of $9.81 billion. Increasing guidance range for branded postpaid net customer additions to 3.0 - 3.6 million from 2.8 - 3.5 million.
UNP Union Pacific (UNP) said Q2 EPS were $1.45, up from $1.17 in the year-ago period and topping the CapIQ mean for $1.39. Sales rose 10% to $5.25 billion from last year and were above estimates for $5.19 billion.
Copyright dailystockplays.com All Rights Reserved